We are live on !
Find out more
PCA
Private Capital Advisors Portfolio holdings
AUM
$1.15B
Turnover
18.82%
1-Year Est. Return
43.46%
This Fund
S&P 500
This Quarter Est. Return
+3.34%
1 Year Est. Return
+43.46%
3 Year Est. Return
+131.91%
5 Year Est. Return
+229.29%
10 Year Est. Return
+757.55%
AUM
$266M
AUM Growth
-$43.4M
(-14%)
Cap. Flow
-$44.2M
Cap. Flow % of AUM
Cap. Flow %
-16.65%
Top 10 Holdings %
Top 10 Hldgs %
25.48%
Holding
127
New
7
Increased
6
Reduced
50
Closed
22
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$4.06M |
| 2 |
Catalyst Pharmaceutical
CPRX
|
+$2.27M |
| 3 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
+$1.93M |
| 4 |
Ionis Pharmaceuticals
IONS
|
+$1.56M |
| 5 |
Axon Enterprise
AXON
|
+$1.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RH
RH
|
+$13M |
| 2 |
MacroGenics
MGNX
|
+$6.84M |
| 3 |
Alibaba
BABA
|
+$3.42M |
| 4 |
SANGAMO THERAPEUTICS INC
SGMO
|
+$3.21M |
| 5 |
HCA Healthcare
HCA
|
+$2.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.9% |
| 2 | Communication Services | 19.6% |
| 3 | Energy | 16.27% |
| 4 | Industrials | 12.61% |
| 5 | Technology | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Boeing
BA
$150B
| – | – |
-8,185
| Closed | -$1.04M | – |
|
|
102
Alibaba
BABA
$271B
| – | – |
-38,500
| Closed | -$3.42M | – |
|
103
Freeport-McMoran
FCX
$100B
| – | – |
-7,600
| Closed | -$248K | – |
|
104
Las Vegas Sands
LVS
$24.6B
| – | – |
-7,300
| Closed | -$454K | – |
|
105
Meta Platforms (Facebook)
META
$1.81T
| – | – |
-21,086
| Closed | -$1.67M | – |
|
106
Opko Health
OPK
$1.14B
| – | – |
-137,000
| Closed | -$1.17M | – |
|
|
107
RH
RH
$2.14B
| – | – |
-163,733
| Closed | -$13M | – |
|
|
108
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| – | – |
-298,000
| Closed | -$3.21M | – |
|
109
Vodafone
VOD
$37.3B
| – | – |
-59,706
| Closed | -$1.96M | – |
|
110
Wynn Resorts
WYNN
$7.78B
| – | – |
-2,500
| Closed | -$468K | – |
|
|
ICPT
111
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| – | – |
-4,300
| Closed | -$1.02M | – |
|
|
CLVS
112
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-20,500
| Closed | -$930K | – |
|
|
STML
113
DELISTED
Stemline Therapeutics, Inc.
STML
| – | – |
-31,064
| Closed | -$387K | – |
|
|
VIAB
114
DELISTED
Viacom Inc. Class B
VIAB
| – | – |
-5,500
| Closed | -$423K | – |
|
115
DELISTED
Mobileye N.V.
MBLY
| – | – |
-22,300
| Closed | -$1.2M | – |
|
|
NPSP
116
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| – | – |
-16,000
| Closed | -$416K | – |
|
|
TI
117
DELISTED
Telecom Italia
TI
| – | – |
-11,500
| Closed | -$132K | – |
|
Similar funds
AIC
CFP
HT
AA
CIG
CIS
FWM
Private Capital Advisors's Q4 2014 Portfolio in Review
As of Q4 2014, Private Capital Advisors held 127 positions worth $266M, down 14% from $309M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Private Capital Advisors withdrew a net $44.2M in Q4 2014, closing 22 positions and reducing 50 holdings. Its most notable exit was RH, an estimated $13M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Communication Services and Energy.
Against the trend, Private Capital Advisors opened a new position in Catalyst Pharmaceutical worth $2.46M.
- Private Capital Advisors's largest Q4 2014 buy was Catalyst Pharmaceutical: 826,500 shares worth $2.46M.
- Private Capital Advisors added most to Qualcomm in Q4 2014, an estimated $4.06M increase.
- Private Capital Advisors's biggest Q4 2014 reduction was MacroGenics, cutting an estimated $6.84M.
- Private Capital Advisors fully exited RH in Q4 2014, selling an estimated $13M.
- Private Capital Advisors's ten largest holdings make up 25% of its $266M portfolio in Q4 2014.
- Private Capital Advisors opened 7 new positions and closed 22 in Q4 2014.
- Private Capital Advisors's portfolio value fell 14% quarter-over-quarter to $266M.
Based on Private Capital Advisors's 13F filing for Q4 2014, filed 29 Jan 2015.